Home›Screener›NVS›Profile

D

36/100

Novartis AG

NVSDiversified Pharma

← Signals View

📋

Analyst Summary

✓ VERIFIED2026-04-11

Novartis AG (NVS) is the lead sponsor of 200 active clinical trials listed on ClinicalTrials.gov^[5], including 57 Phase 3^[1], 58 Phase 2^[2], 30 Phase 1^[3], 14 Phase 4^[4].

Trial NCT05948943^[6] evaluates Alpelisib in Lymphatic Malformations with a target enrollment of 232 participants. Trial NCT05939414^[7] evaluates AAA617 in Oligometastatic Prostate Cancer (OMPC) with a target enrollment of 450 participants. Trial NCT05156281^[8] evaluates Remibrutinib in Relapsing Multiple Sclerosis with a target enrollment of 1011 participants.

No Form 4 insider filings for NVS were recorded at the SEC in the past 30 days^[9].

Sources

ClinicalTrials.gov (2026-04-11) ↗
ClinicalTrials.gov (2026-04-11) ↗
ClinicalTrials.gov (2026-04-11) ↗
ClinicalTrials.gov (2026-04-11) ↗
ClinicalTrials.gov (2026-04-11) ↗
ClinicalTrials.gov · NCT05948943 (2026-04-08) ↗
ClinicalTrials.gov · NCT05939414 (2026-03-23) ↗
ClinicalTrials.gov · NCT05156281 (2026-03-30) ↗
SEC EDGAR · 0001114448 (2026-04-11) ↗

🏛

Upcoming Catalysts

remibrutinib — chronic spontaneous urticaria

2027-06-22

in 383d

🔬

Clinical Trials

200

NCT01742299GIST and CML

clinicaltrials_gov · Retrieved 2026-04-11

NCT02393625ALK-positive NSCLC

clinicaltrials_gov · Retrieved 2026-04-11

NCT02445222Long Term Safety of Patients Receiving CAR-T in an Eligible Clinical Trial or Managed Access Program

clinicaltrials_gov · Retrieved 2026-04-11

NCT02934568Continued Access to Study Treatment(s), Cancers With a Mass, Bulky Tumor, Nodule, Lump, Advanced Cancer, Advanced Solid Tumors, Advanced Solid Malignancies

clinicaltrials_gov · Retrieved 2026-04-11

NCT02962414Tuberous Sclerosis Complex

clinicaltrials_gov · Retrieved 2026-04-11

NCT03040973Advanced Solid Tumors Which Are cMET-dependent

clinicaltrials_gov · Retrieved 2026-04-11

NCT03333343EGFR-mutant Non-small Cell Lung Cancer

clinicaltrials_gov · Retrieved 2026-04-11

NCT03340506Melanoma, Non Small Cell Lung Cancer, Solid Tumor, Rare Cancers, High Grade Glioma

clinicaltrials_gov · Retrieved 2026-04-11

NCT03421977Spinal Muscular Atrophy 1

clinicaltrials_gov · Retrieved 2026-04-11

NCT03650114Relapsing Multiple Sclerosis

clinicaltrials_gov · Retrieved 2026-04-11

NCT03814746Sickle Cell Disease (SCD)

clinicaltrials_gov · Retrieved 2026-04-11

NCT03827798Hidradenitis Suppurativa

clinicaltrials_gov · Retrieved 2026-04-11

NCT03876769B-Cell Acute Lymphoblastic Leukemia

clinicaltrials_gov · Retrieved 2026-04-11

NCT03945318IgA Nephropathy

clinicaltrials_gov · Retrieved 2026-04-11

NCT03955445C3 Glomerulopathy, Immune-complex-membranoproliferative Glomerulonephritis

clinicaltrials_gov · Retrieved 2026-04-11

NCT03975829Diffuse Astrocytoma, Anaplastic Astrocytoma, Astrocytoma, Oligodendroglioma, Childhood, Anaplastic Oligodendroglioma, Glioblastoma, Pilocytic Astrocytoma, Giant Cell Astrocytoma, Pleomorphic Xanthoastrocytoma, Anaplastic Pleomorphic Xanthoastrocytoma, Angiocentric Glioma, Chordoid Glioma of Third Ventricle, Gangliocytoma, Ganglioglioma, Anaplastic Ganglioglioma, Dysplastic Gangliocytoma of Cerebrellum, Desmoplastic Infantile Astrocytoma and Ganglioglioma, Papillary Glioneuronal Tumor, Rosette-forming Glioneuronal Tumor, Central Neurocytoma, Extraventricular Neurocytoma, Cerebellar Liponeurocytoma, Neurofibromatosis Type 1

clinicaltrials_gov · Retrieved 2026-04-11

NCT04023552Cardiovascular Disease and Lipoprotein(a)

clinicaltrials_gov · Retrieved 2026-04-11

NCT04042025Spinal Muscular Atrophy Type I, Spinal Muscular Atrophy Type II, Spinal Muscular Atrophy Type III, SMA

clinicaltrials_gov · Retrieved 2026-04-11

NCT04058756Advanced Solid Tumors

clinicaltrials_gov · Retrieved 2026-04-11

NCT04174157Spinal Muscular Atrophy (SMA)

clinicaltrials_gov · Retrieved 2026-04-11

NCT04179175Hidradenitis Suppurativa

clinicaltrials_gov · Retrieved 2026-04-11

NCT04208178Advanced HER2+Breast Cancer

clinicaltrials_gov · Retrieved 2026-04-11

NCT04417621Melanoma

clinicaltrials_gov · Retrieved 2026-04-11

NCT04516369Biallelic RPE65 Mutation-associated Retinal Dystrophy

clinicaltrials_gov · Retrieved 2026-04-11

NCT04524000Advanced Breast Cancer

clinicaltrials_gov · Retrieved 2026-04-11

NCT04557462Primary IgA Nephropathy

clinicaltrials_gov · Retrieved 2026-04-11

NCT04573920IgA Nephropathy, Focal Segmental Glomerulosclerosis, Alport Syndrome, Diabetic Kidney Disease, Diabetic Nephropathy Type 2, Immunoglobulin A Nephropathy

clinicaltrials_gov · Retrieved 2026-04-11

NCT04589650PIK3CA-related Overgrowth Spectrum (PROS)

clinicaltrials_gov · Retrieved 2026-04-11

NCT04603495Myelofibrosis, Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis

clinicaltrials_gov · Retrieved 2026-04-11

NCT04666272Melanoma

clinicaltrials_gov · Retrieved 2026-04-11

NCT04720157Prostatic Neoplasms

clinicaltrials_gov · Retrieved 2026-04-11

NCT04727723Gastroenteropancreatic Neuroendocrine Tumor

clinicaltrials_gov · Retrieved 2026-04-11

NCT04747613Paroxysmal Nocturnal Hemoglobinuria

clinicaltrials_gov · Retrieved 2026-04-11

NCT04765657Hypercholesterolemia

clinicaltrials_gov · Retrieved 2026-04-11

NCT04797000Myelodysplastic Syndromes

clinicaltrials_gov · Retrieved 2026-04-11

NCT04817618C3G

clinicaltrials_gov · Retrieved 2026-04-11

NCT04925479Myeloid Leukemia, Philadelphia Positive

clinicaltrials_gov · Retrieved 2026-04-11

NCT04933552Multiple Sclerosis

clinicaltrials_gov · Retrieved 2026-04-11

NCT04939610Solid Tumor

clinicaltrials_gov · Retrieved 2026-04-11

NCT04971226Chronic Myeloid Leukemia (CML) Philadelphia Chromosome Positive

clinicaltrials_gov · Retrieved 2026-04-11

NCT04980833PIK3CA-related Overgrowth Spectrum (PROS)

clinicaltrials_gov · Retrieved 2026-04-11

NCT04985487Neovascular Age-related Macular Degeneration

clinicaltrials_gov · Retrieved 2026-04-11

NCT05030428Atherosclerotic Cardiovascular Disease

clinicaltrials_gov · Retrieved 2026-04-11

NCT05038735Breast Cancer

clinicaltrials_gov · Retrieved 2026-04-11

NCT05067140Prostate Cancer Metastatic

clinicaltrials_gov · Retrieved 2026-04-11

NCT05090371Relapsing-Remitting Multiple Sclerosis

clinicaltrials_gov · Retrieved 2026-04-11

NCT05109728Glioblastoma

clinicaltrials_gov · Retrieved 2026-04-11

NCT05114746Prostate Cancer

clinicaltrials_gov · Retrieved 2026-04-11

NCT05126277Lupus Nephritis

clinicaltrials_gov · Retrieved 2026-04-11

NCT05132075Non-Small Cell Lung Cancer

clinicaltrials_gov · Retrieved 2026-04-11

NCT05142696Extensive Stage Small Cell Lung Cancer

clinicaltrials_gov · Retrieved 2026-04-11

NCT05147220Relapsing Multiple Sclerosis

clinicaltrials_gov · Retrieved 2026-04-11

NCT05156281Relapsing Multiple Sclerosis

clinicaltrials_gov · Retrieved 2026-04-11

NCT05201066Myelodysplastic Syndromes, Leukemia, Myelomonocytic, Chronic

clinicaltrials_gov · Retrieved 2026-04-11

NCT05222529Asthma

clinicaltrials_gov · Retrieved 2026-04-11

NCT05252585Renal Angiomyolipoma

clinicaltrials_gov · Retrieved 2026-04-11

NCT05293470Breast Cancer

clinicaltrials_gov · Retrieved 2026-04-11

NCT05335876Spinal Muscular Atrophy (SMA)

clinicaltrials_gov · Retrieved 2026-04-11

NCT05344469Relapsing Multiple Sclerosis

clinicaltrials_gov · Retrieved 2026-04-11

NCT05358249KRAS G12C Mutant Solid Tumors, Carcinoma, Non-Small Cell Lung, Carcinoma, Non-Small-Cell Lung, Non-Small Cell Lung Cancer, Non-Small Cell Lung Carcinoma, Nonsmall Cell Lung Cancer, Colorectal Cancer, Colorectal Carcinoma, Colorectal Neoplasms, Colorectal Tumors, Neoplasms, Colorectal

clinicaltrials_gov · Retrieved 2026-04-11

NCT05360446Coronary Artery Disease

clinicaltrials_gov · Retrieved 2026-04-11

NCT05384587Chronic Myelogenous Leukemia - Chronic Phase

clinicaltrials_gov · Retrieved 2026-04-11

NCT05397496B-cell Non-Hodgkin Lymphoma (B-NHL), B-cell Acute Lymphoblastic Leukemia (B-ALL)

clinicaltrials_gov · Retrieved 2026-04-11

NCT05445843Locally Advanced or Metastatic KRAS G12C-mutated NSCLC With a PD-L1 Expression <1% or a PD-L1 Expression ≥ 1% and an STK11 Co-mutation

clinicaltrials_gov · Retrieved 2026-04-11

NCT05513001Chronic Spontaneous Urticaria

clinicaltrials_gov · Retrieved 2026-04-11

NCT05548062Polycythemia Vera

clinicaltrials_gov · Retrieved 2026-04-11

NCT05562466Asthma

clinicaltrials_gov · Retrieved 2026-04-11

NCT05622708Non-radiographic Axial Spondyloarthritis

clinicaltrials_gov · Retrieved 2026-04-11

NCT05624749Systemic Lupus Erythematosus

clinicaltrials_gov · Retrieved 2026-04-11

NCT05634967Multiple Sclerosis, Pregnancy

clinicaltrials_gov · Retrieved 2026-04-11

NCT05639114Systemic Lupus Erythematosus

clinicaltrials_gov · Retrieved 2026-04-11

NCT05646381Aortic Stenosis

clinicaltrials_gov · Retrieved 2026-04-11

NCT05653219Primary Immune Thrombocytopenia

clinicaltrials_gov · Retrieved 2026-04-11

NCT05658003Metastatic Castration-Resistant Prostate Cancer (mCRPC)

clinicaltrials_gov · Retrieved 2026-04-11

NCT05670106Metastatic Castration-Resistant Prostate Cancer (mCRPC)

clinicaltrials_gov · Retrieved 2026-04-11

NCT05677451Chronic Spontaneous Urticaria

clinicaltrials_gov · Retrieved 2026-04-11

NCT05697146Breast Cancer

clinicaltrials_gov · Retrieved 2026-04-11

NCT05703516Non-Small-Cell Lung Carcinoma

clinicaltrials_gov · Retrieved 2026-04-11

NCT05739383Primary Prevention of Atherosclerotic Cardiovascular Disease

clinicaltrials_gov · Retrieved 2026-04-11

NCT05750628Uncomplicated Plasmodium Falciparum Malaria

clinicaltrials_gov · Retrieved 2026-04-11

NCT05798117Systemic Lupus Erythematosus, Lupus Nephritis

clinicaltrials_gov · Retrieved 2026-04-11

NCT05803941Prostate Cancer

clinicaltrials_gov · Retrieved 2026-04-11

NCT05838768MSIhi or dMMR Advanced Unresectable or Metastatic Solid Tumors, Including Colorectal Cancers

clinicaltrials_gov · Retrieved 2026-04-11

NCT05849298Prostatic Neoplasm

clinicaltrials_gov · Retrieved 2026-04-11

NCT05868629Rare Unresectable or Metastatic BRAF V600E Mutation-positive Solid Tumors

clinicaltrials_gov · Retrieved 2026-04-11

NCT05885555Primary Immune Thrombocytopenia (ITP)

clinicaltrials_gov · Retrieved 2026-04-11

NCT05900141Hyperlipoproteinemia (a)

clinicaltrials_gov · Retrieved 2026-04-11

NCT05921994Hidradenitis Suppurativa

clinicaltrials_gov · Retrieved 2026-04-11

NCT05935215Atypical Hemolytic Uremic Syndrome

clinicaltrials_gov · Retrieved 2026-04-11

NCT05939414Oligometastatic Prostate Cancer (OMPC)

clinicaltrials_gov · Retrieved 2026-04-11

NCT05948943Lymphatic Malformations

clinicaltrials_gov · Retrieved 2026-04-11

NCT05959304Diabetic Macular Edema

clinicaltrials_gov · Retrieved 2026-04-11

NCT05976243Chronic Inducible Urticaria

clinicaltrials_gov · Retrieved 2026-04-11

NCT05983198Prostate Cancer

clinicaltrials_gov · Retrieved 2026-04-11

NCT05985915Sjogrens Syndrome

clinicaltrials_gov · Retrieved 2026-04-11

NCT05996835Acute Kidney Injury Due to Sepsis

clinicaltrials_gov · Retrieved 2026-04-11

NCT06019637Spinal Muscular Atrophies

clinicaltrials_gov · Retrieved 2026-04-11

NCT06075758Breast Cancer

clinicaltrials_gov · Retrieved 2026-04-11

NCT06092879Chronic Myeloid Leukemia

clinicaltrials_gov · Retrieved 2026-04-11

NCT06142357Moderate-to-severe Plaque Psoriasis

clinicaltrials_gov · Retrieved 2026-04-11

NCT06148506HR+HER2- Advanced Breast Cancer

clinicaltrials_gov · Retrieved 2026-04-11

NCT06156683Multiple Sclerosis

clinicaltrials_gov · Retrieved 2026-04-11

NCT06157086Multiple Sclerosis (MS)

clinicaltrials_gov · Retrieved 2026-04-11

NCT06267560Elevated Lp(a) and Established Atherosclerotic Cardiovascular Disease

clinicaltrials_gov · Retrieved 2026-04-11

NCT06275724Familial Hypercholesterolaemia, Hypercholesterolaemia

clinicaltrials_gov · Retrieved 2026-04-11

NCT06287268Aplastic Anemia

clinicaltrials_gov · Retrieved 2026-04-11

NCT06335979Systemic Lupus Erythematosus, SLE

clinicaltrials_gov · Retrieved 2026-04-11

NCT06345157Multiple Sclerosis, Relapsing-Remitting

clinicaltrials_gov · Retrieved 2026-04-11

NCT06379217Metastatic Neuroendocrine Prostate Cancer

clinicaltrials_gov · Retrieved 2026-04-11

NCT06386419Primary Hypercholesterolemia, Mixed Dyslipidemia

clinicaltrials_gov · Retrieved 2026-04-11

NCT06388941Anti-Neutrophil Cytoplasm Antibodies (ANCA) Associated Vasculitis

clinicaltrials_gov · Retrieved 2026-04-11

NCT06401356Hematologic Malignancy, Solid Tumor, Advanced Malignancies

clinicaltrials_gov · Retrieved 2026-04-11

NCT06427811Philadelphia Chromosome-Positive Chronic Myeloid Leukemia in Chronic Phase

clinicaltrials_gov · Retrieved 2026-04-11

NCT06439082Sickle Cell Disease

clinicaltrials_gov · Retrieved 2026-04-11

NCT06444087Hidradenitis Suppurativa

clinicaltrials_gov · Retrieved 2026-04-11

NCT06462469Steroid-refractory Acute Graft Versus Host Disease

clinicaltrials_gov · Retrieved 2026-04-11

NCT06470048Diffuse Cutaneous Systemic Sclerosis

clinicaltrials_gov · Retrieved 2026-04-11

NCT06486779Relapsing Multiple Sclerosis (RMS)

clinicaltrials_gov · Retrieved 2026-04-11

NCT06501443Hypercholesterolaemia

clinicaltrials_gov · Retrieved 2026-04-11

NCT06514521Metastatic Castration-resistant Prostate Cancer

clinicaltrials_gov · Retrieved 2026-04-11

NCT06514534Chronic Myeloid Leukemia (CML)

clinicaltrials_gov · Retrieved 2026-04-11

NCT06517719Metastatic Castration Resistant Prostate Cancer

clinicaltrials_gov · Retrieved 2026-04-11

NCT06517732Hidradenitis Suppurativa

clinicaltrials_gov · Retrieved 2026-04-11

NCT06531499Metastatic Castration-Resistant Prostate Cancer

clinicaltrials_gov · Retrieved 2026-04-11

NCT06581198Lupus Erythematosus, Systemic, Lupus Nephritis

clinicaltrials_gov · Retrieved 2026-04-11

NCT06597006Familial Hypercholesterolemia - Homozygous

clinicaltrials_gov · Retrieved 2026-04-11

NCT06597019Familial Hypercholesterolemia - Heterozygous

clinicaltrials_gov · Retrieved 2026-04-11

NCT06604897Essential Hypertension

clinicaltrials_gov · Retrieved 2026-04-11

NCT06617793Relapsing Multiple Sclerosis

clinicaltrials_gov · Retrieved 2026-04-11

NCT06625333HR+HER2- Advanced Breast Cancer

clinicaltrials_gov · Retrieved 2026-04-11

NCT06632600Chagas Disease

clinicaltrials_gov · Retrieved 2026-04-11

NCT06649110Healthy Volunteers, Pulmonary Arterial Hypertension

clinicaltrials_gov · Retrieved 2026-04-11

NCT06659393Pediatric Chronic Heart Failure

clinicaltrials_gov · Retrieved 2026-04-11

NCT06665256Idiopathic Inflammatory Myopathies

clinicaltrials_gov · Retrieved 2026-04-11

NCT06675864Progressive Multiple Sclerosis

clinicaltrials_gov · Retrieved 2026-04-11

NCT06684964Chronic Myelogenous Leukemia in Chronic Phase

clinicaltrials_gov · Retrieved 2026-04-11

NCT06711887Lupus Nephritis

clinicaltrials_gov · Retrieved 2026-04-11

NCT06726148Advanced HR+/HER2- Breast Cancer, Advanced CCNE1-amplified Solid Tumors

clinicaltrials_gov · Retrieved 2026-04-11

NCT06744920Generalized Myasthenia Gravis

clinicaltrials_gov · Retrieved 2026-04-11

NCT06751238Juvenile Psoriatic Arthritis

clinicaltrials_gov · Retrieved 2026-04-11

NCT06780670Prostate Cancer

clinicaltrials_gov · Retrieved 2026-04-11

NCT06784752Somatostatin Receptor Positive (SSTR+), Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET)

clinicaltrials_gov · Retrieved 2026-04-11

NCT06785675Hidradenitis Suppurativa

clinicaltrials_gov · Retrieved 2026-04-11

NCT06785779Hidradenitis Suppurativa (HS)

clinicaltrials_gov · Retrieved 2026-04-11

NCT06785818B-Cell Acute Lymphoblastic Leukemia, Diffuse Large B-Cell Lymphoma, Follicular Lymphoma

clinicaltrials_gov · Retrieved 2026-04-11

NCT06797531HR+/HER2- Early Breast Cancer

clinicaltrials_gov · Retrieved 2026-04-11

NCT06799000Hidradenitis Suppurativa

clinicaltrials_gov · Retrieved 2026-04-11

NCT06830720Breast Neoplasms

clinicaltrials_gov · Retrieved 2026-04-11

NCT06838143Hereditary Periodic Fever Syndromes, Cryopyrin-associated Periodic Syndromes (CAPS), Colchicine Resistance Familial Mediterranean Fever (crFMF), TNF Receptor Associated Periodic Syndrome (TRAPS), Hyper-IgD Syndrome / Mevalonate Kinase Deficiency (HIDS/MKD), Systemic Juvenile Idiopathic Arthritis (sJIA)

clinicaltrials_gov · Retrieved 2026-04-11

NCT06840392Hidradenitis Suppurativa

clinicaltrials_gov · Retrieved 2026-04-11

NCT06846281Relapsing Multiple Sclerosis

clinicaltrials_gov · Retrieved 2026-04-11

NCT06855277Prostate Cancer

clinicaltrials_gov · Retrieved 2026-04-11

NCT06857955Hypertension

clinicaltrials_gov · Retrieved 2026-04-11

NCT06858319Kidney Diseases, Kidney Diseases, Chronic, Urological Diseases, Glomerulonephritis, Glomerular Disease, Glomerulonephritis, IGA, Glomerulopathy, Immunoglobulin Disease

clinicaltrials_gov · Retrieved 2026-04-11

NCT06858332Atherosclerotic Cardiovascular Disease

clinicaltrials_gov · Retrieved 2026-04-11

NCT06865651Chronic Urticaria (CU): Chronic Inducible Urticaria (CINDU) and Chronic Spontaneous Urticaria (CSU)

clinicaltrials_gov · Retrieved 2026-04-11

NCT06868212Chronic Spontaneous Urticaria (CSU)

clinicaltrials_gov · Retrieved 2026-04-11

NCT06869785Relapsing Multiple Sclerosis (RMS)

clinicaltrials_gov · Retrieved 2026-04-11

NCT06875973Atherosclerotic Cardiovascular Disease

clinicaltrials_gov · Retrieved 2026-04-11

NCT06894511Metastatic Castration Resistant Prostate Cancer (mCRPC)

clinicaltrials_gov · Retrieved 2026-04-11

NCT06903234Hemoglobinuria, Paroxysmal

clinicaltrials_gov · Retrieved 2026-04-11

NCT06905288Ankylosing Spondylitis

clinicaltrials_gov · Retrieved 2026-04-11

NCT06905301Breast Cancer

clinicaltrials_gov · Retrieved 2026-04-11

NCT06910813Nephropathic Cystinosis

clinicaltrials_gov · Retrieved 2026-04-11

NCT06930859Breast Cancer

clinicaltrials_gov · Retrieved 2026-04-11

NCT06931691Paroxysmal Nocturnal Hemoglobinuria

clinicaltrials_gov · Retrieved 2026-04-11

NCT06941792Coronary Heart Disease

clinicaltrials_gov · Retrieved 2026-04-11

NCT06958315Atherosclerotic Vascular Disease, Heterozygous Familial Hypercholesterolemia

clinicaltrials_gov · Retrieved 2026-04-11

NCT06991556Metastatic Hormone-sensitive Prostate Cancer

clinicaltrials_gov · Retrieved 2026-04-11

NCT06991608Chronic Spontaneous Urticaria

clinicaltrials_gov · Retrieved 2026-04-11

NCT06997588PIK3CA-related Overgrowth Spectrum (PROS)

clinicaltrials_gov · Retrieved 2026-04-11

NCT07006727Small Cell Lung Carcinoma, Large Cell Neuroendocrine Carcinoma of the Lung, Neuroendocrine Prostate Cancer, Gastroenteropancreatic Neuroendocrine Carcinoma

clinicaltrials_gov · Retrieved 2026-04-11

NCT07029542C3 Glomerulopathy

clinicaltrials_gov · Retrieved 2026-04-11

NCT07029555Rheumatoid Arthritis

clinicaltrials_gov · Retrieved 2026-04-11

NCT07034690Atherosclerotic Cardiovascular Disease

clinicaltrials_gov · Retrieved 2026-04-11

NCT07036718Paroxysmal Nocturnal Hemoglobinuria

clinicaltrials_gov · Retrieved 2026-04-11

NCT07047118Prostatic Cancer, Castration-Resistant

clinicaltrials_gov · Retrieved 2026-04-11

NCT07093801Metastatic Castration Resistant Prostate Cancer

clinicaltrials_gov · Retrieved 2026-04-11

NCT07102628Acute Coronary Syndrome

clinicaltrials_gov · Retrieved 2026-04-11

NCT07140614Charcot-Marie-Tooth Disease, Type 1A

clinicaltrials_gov · Retrieved 2026-04-11

NCT07142265Myocardial Infarction

clinicaltrials_gov · Retrieved 2026-04-11

NCT07156149C3 Glomerulopathy

clinicaltrials_gov · Retrieved 2026-04-11

NCT07174063Metastatic Prostate Cancer (mCRPC)

clinicaltrials_gov · Retrieved 2026-04-11

NCT07190300Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)

clinicaltrials_gov · Retrieved 2026-04-11

NCT07203001Still´s Disease

clinicaltrials_gov · Retrieved 2026-04-11

NCT07206056Progressive Metastatic Castrate Resistant Prostate Cancer

clinicaltrials_gov · Retrieved 2026-04-11

NCT07217067Atrial Fibrillation

clinicaltrials_gov · Retrieved 2026-04-11

NCT07235046Lipoprotein Disorder

clinicaltrials_gov · Retrieved 2026-04-11

NCT07243002Breast Cancer

clinicaltrials_gov · Retrieved 2026-04-11

NCT07249463Cryptosporidiosis

clinicaltrials_gov · Retrieved 2026-04-11

NCT07261631Pancreatic Ductal Adenocarcinoma, Non-Small Cell Lung Cancer, HR+/HER2- Ductal and Lobular Breast Cancer, Triple Negative Breast Cancer, Colorectal Cancer, Soft Tissue Sarcoma

clinicaltrials_gov · Retrieved 2026-04-11

NCT07282015Hidradenitis Suppurativa

clinicaltrials_gov · Retrieved 2026-04-11

NCT07408219Chronic Spontaneous Urticaria

clinicaltrials_gov · Retrieved 2026-04-11

NCT07431177Non-segmental Vitiligo

clinicaltrials_gov · Retrieved 2026-04-11

NCT07441642Geographic Atrophy Secondary to Age-related Macular Degeneration

clinicaltrials_gov · Retrieved 2026-04-11

NCT07467993Schizophrenia

clinicaltrials_gov · Retrieved 2026-04-11

NCT07476170HR+/HER2- Advanced or Metastatic Breast Cancer

clinicaltrials_gov · Retrieved 2026-04-11

NCT07504783Multiple Sclerosis

clinicaltrials_gov · Retrieved 2026-04-11

NCT07508007Implementing EAS/ESC Guideline Recommendation on Lp(a) Testing in Routine Practice

clinicaltrials_gov · Retrieved 2026-04-11

NCT07517263Cardiovascular Disease and Lipoprotein(a)

clinicaltrials_gov · Retrieved 2026-04-11

👤

Insider Activity

1

0 filings

sec_edgar · Retrieved 2026-04-11

Not financial advice. BiotechSigns profiles are AI-generated from verified public sources (ClinicalTrials.gov, SEC EDGAR) and are for informational purposes only. Always do your own due diligence before making investment decisions.

Score Breakdown

Score Trend

2026-04-132026-06-02

Signal Summary

PDUFA Dates1

Insider Filings1

Clinical Trials1

Sector Peers (Diversified Pharma)

JNJJohnson & Johnson

C

Data Provenance

cik1 verified

clinical trial200 verified

insider buy1 verified

trial count5 verified

Every claim backed by source URL from ClinicalTrials.gov or SEC EDGAR